A little-known advisory group to the US Food and Drug Administration will meet this week to mull over whether to ease ...
A mind-bending hallucinogen is moving out of the counterculture and into the clinic. The Food and Drug Administration on Friday greenlit the first-ever human clinical trial of an ibogaine derivative ...
The agency is considering whether compounding pharmacies should be allowed to produce BPC-157, TB-500 and other previously ...
The Food and Drug Administration (FDA) has announced the winners of national priority vouchers to study the therapeutic effects of psychedelic drugs, less than a week after President Donald Trump ...
Jessica Rendall is a reporter with experience covering a variety of health and wellness topics, including chronic disease, infectious disease, telemedicine, mental health and health technology. Kelly ...
A first-of-its-kind drug may slow the progression of Huntington's disease, a rare, fatal, neurodegenerative disorder.
Follow this section to personalize your feed and get instant alerts. WHY FOLLOW? Update your preferences in Account Settings Personalized Content Follow this tag to personalize your feed and get ...
Marty Makary resigned as FDA commissioner amid controversy. But his reforms to drug review times and AI are the agency's ...
America is looking to catch up to worldwide trends for sun protection. The Food and Drug Administration announced a proposal on Dec. 11 to allow the addition of bemotrizinol to sunscreen – an ...